An open letter to the American people from 83 participants in the Health Policy Consensus Group and other health care leaders The COVID-19 crisis has highlighted the need for flexibility in our health sector and for public officials to do more to empower medical professionals and health care innovators to provide the care and coverage people want and need. Those goals must guide our … [Read more...] about Responding to the Coronavirus Crisis and Building a Stronger Health Sector for the Future
Published on FORBES.com | The Trump administration finalized a new rule late today that offers important opportunities for businesses, especially small employers, to offer more health coverage options for their workers and for employees to have much more flexibility and control over their health care dollars. The rule undoes an Obama administration action that forbade workers … [Read more...] about New Administration Action Could Give 11 Million Workers More Health Insurance Options
Last fall, I wrote in Forbes about U.S. based biotechnology manufacturer Amgen announcing it was slashing the list price of its breakthrough cholesterol-lowering drug Repatha by 60% in an effort to improve access and affordability for patients. Too many patients who had been prescribed the drug were walking away from the pharmacy empty handed because of sticker shock over … [Read more...] about A Closer Look At The Drug Rebate Proposal
Critics cried sabotage when political leaders took action to repair some of the damage done by the Affordable Care Act. They saw sinister motives behind the decision by the last Congress to repeal the individual mandate and in Trump administration regulations that made more affordable health insurance options available to individuals and small groups. But a new study by the … [Read more...] about The Costs of Government’s Benevolent Coercion
If they said it once, they said it 200 at times. At a recent hearing before the House Energy and Commerce Health subcommittee (live-streamed here), the majority members repeatedly called the new Short Term Limited Duration plan option “Junk Plans.” In my testimony, I talked about the benefits these plans offer to people who are between jobs, young people in the gig economy, early … [Read more...] about Do Democrats Want to Roll Back Consumer-Friendly Health Options?
Galen Institute president Grace-Marie Turner testified before the House Energy and Commerce Committee on Feb. 13 about preserving consumer protections in health insurance while giving consumers more choices of affordable coverage. She focused on: The Trump administration’s Section 1332 guidance which gives states new authority to help their individual and small group markets heal … [Read more...] about Preserving Patient Choice for Affordable Coverage
The pre-existing condition scare tactics continue. I testified yesterday—as the sole witness called by the Republican minority—during a House Education and Labor Committee hearing on “Examining Threats to Workers with Preexisting Conditions.” It was the first hearing of the new Congress under the new Chairman Bobby Scott, D-VA, and virtually all members on both sides of the … [Read more...] about Preview Of The Coming Medicare For All Debate